Antibiotic Treatment for Common Infections

Introduction

Antibiotic treatment guidelines for common infections are established by various medical societies, including the American Academy of Otolaryngology-Head and Neck Surgery, the Infectious Diseases Society of America (IDSA), the American Academy of Pediatrics (AAP), and the Clinical Microbiology and Infection society 1, 2, 3, 4

The American Academy of Otolaryngology-Head and Neck Surgery recommends a dosage of 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate for every 12 hours regimen for children with otitis media, sinusitis, lower respiratory tract infections, and more severe infections 5
High-dose amoxicillin-clavulanate (90 mg/kg/day) is recommended for children with otitis media, sinusitis, and lower respiratory tract infections, particularly in areas with high prevalence of resistant organisms, such as penicillin-nonsusceptible Streptococcus pneumoniae 5
For neonates (0-4 weeks), the AAP recommends ampicillin dosing as follows:
The following table outlines the recommended doses of ampicillin based on postnatal age and weight:
| Postnatal Age | Weight | Recommended Dose | | --- | --- | --- | | ≤7 days | ≤2000 g | 50 mg/kg/day every 12 hours | | ≤7 days | >2000 g | 75 mg/kg/day every 8 hours | | >7 days | <1200 g | 50 mg/kg/day every 12 hours | | >7 days | 1200-2000 g | 75 mg/kg/day every 8 hours | | >7 days | >2000 g | 100 mg/kg/day every 6 hours |

The typical treatment duration is 10-14 days, as recommended by the IDSA 1
For uncomplicated pneumonia cases, the AAP recommends a treatment duration of 5-7 days 3, 6
For acute otitis media, the AAP recommends a treatment duration of 5-10 days, with 5 days for children over 2 years and 8-10 days for children under 2 years 3
The Clinical Microbiology and Infection society also recommends a treatment duration of 5-10 days for acute otitis media 4
Treatment should continue for a minimum of 48-72 hours beyond symptom resolution, although the specific guideline society is not mentioned in the provided reference 7

The American Academy of Otolaryngology-Head and Neck Surgery suggests that standard dosing may be inadequate for areas with high prevalence of resistant organisms, and high-dose regimens should be used to mitigate underdosing risk 5
For patients with severe allergic reactions to penicillin, the AAP recommends Clindamycin (10-20 mg/kg/day in 3 divided doses) 1, 8
The AAP recommends cefuroxime (30 mg/kg/day in divided doses) as an alternative treatment option for non-anaphylactic allergy cases 3
The Clinical Microbiology and Infection society recommends cefpodoxime-proxetil as an alternative treatment option for non-anaphylactic allergy cases 4
If Staphylococcus aureus co-infection is suspected, the IDSA recommends adding vancomycin (40-60 mg/kg/day every 6-8 hours) or clindamycin (40 mg/kg/day every 6-8 hours) based on local susceptibility patterns, with considerations for potential resistance and underlying medical conditions 9

Clinical improvement should be assessed within 48-72 hours, with signs of improvement including decreased respiratory rate, reduced work of breathing, improved oxygen saturation, decreased fever, and improved feeding, as recommended by the American Thoracic Society and the British Thoracic Society 10
Oxygen saturation checks should be performed at least every 4 hours for patients on oxygen therapy, as recommended by the American Thoracic Society and the British Thoracic Society 10
If no improvement is seen within 48-72 hours, reassessment is necessary to consider alternative treatments or adjustments to the current regimen, as suggested by the IDSA 9

The following table outlines the recommended first-line treatment and alternative options for pediatric patients:
| Age | First-line Treatment | Alternative Options | | --- | --- | --- | | <5 years | Amoxicillin (90 mg/kg/day in 2 doses) | Amoxicillin-clavulanate | | ≥5 years | Amoxicillin (90 mg/kg/day in 2 doses, maximum 4 g/day) | Macrolide for atypical pneumonia | | Fully immunized | Ampicillin or penicillin G | Ceftriaxime or cefotaxime | | Not fully immunized or high local resistance | Ceftriaxone or cefotaxime | Vancomycin or clindamycin for MRSA |

Infants under 1 year with mild symptoms of lower respiratory tract infection generally do not need antibiotics, as recommended by the British Thoracic Society 10
Children younger than 2 years, attending childcare, recently treated with antibiotics, or living in areas with high prevalence of resistant organisms should receive the high-dose regimen due to increased likelihood of resistant organisms, as recommended by the AAP 12